OFAMA

Ofama is a business-to-business (B-2-B) e-commerce company platform that supports trade in
pharmaceutical and non-pharmaceuticals. We employ our technology to help players in the supply chain
(manufacturers, distributors/ wholesalers and retailers) leverage their operations through the internet.

Ofama does this by a versatile online business environment where businesses meet up and evaluate each others value offerings and identify areas of trade synergy also ensures the improvement of healthcare supply chain processes that saves businesses money and time in either receiving or delivering value.

By linking these pharmaceutical players in one platform gives access large pharmaceutical market,competitive prices,product sourcing and timely delivery of products to the end user

Ofama will help the community by accessing medicines with cheaper pricing this is due to competitiveness on the pharmaceutical industry.

Market intelligence will help identify  consumption of medicines in different communities and  locations this data will be used to prevent curb emerges of diseases  

The pharmaceutical landscape in Kenya constitutes a number of multinational companies that are present through locally incorporated affiliates, technical representative offices and local technical agents. The presence of these companies has made the industry more competitive, with an emphasis on maintaining both quality and affordability. 

Manufacturing, distribution and retail of pharmaceuticals and medical equipment. The industry is dominated by private companies, with 14 of the leading play.Kenya has a significant, and growing, domestic pharmaceutical market valued at $750 million at the end of 2018, up from $417 million in 2010. The distribution of pharmaceutical products has been increasing due to the rising disease burden in the country. Prescription drugs constitute 70% of the drugs in the market, largely treating non-communicable diseases such as diabetes, hypertension and cancer. 

Challenges facing African countries are counterfeits and illegal trade in pharmaceuticals, reduced government expenditure on drugs, pressure on pricing from health management organizations. (HMOs). increased customer demands and awareness of alternative sources.

So by linking these pharmaceutical players in one platform will greatly impact the communities at large by reduced/affordable  pricing,access quality medications from reliable sources,pharmacovigilance and market intelligence which will be used to know consumption of medicine in different regions

Ofama is a web app that will have all pharmaceutical players on board ie manufactures,distributors, whole sellers and retailers all accredited.

These players will be able to have one market place where they can buy and sell their products competitively,this will go along way in solving the health care supply chain because low pricing due,genuine product etc

The targeted people are the general public who uses medications for communicable  and non communicable diseases their lives will greatly improve due to a good pharmaceutical supply chain that will lower prices and offer quality medication to all regions  

A well managed pharmaceutical supply chain will offer good pharmacy practice to communities,lower prices,quality medicine  and emerges of a disease it will be easy to curb them due to market intelligence offered by ofama platform this will also  help access to primary health care and dependable health supply chains and avert occurrence of perdermics , epidemics and other health care threats

We are three people namely;

TIMOTHY WACHIRA

PAUL KARIUKI

PHILLIP KIMANI 

Global  pharmaceutical manufactures